The company has applied its patented Cross Linked Microstructure (CLM™) process technology to commonly used biocompatible materials to produce both resorbable and permanent implants for a broad range of clinical applications. Data from in vitro and animal testing has shown our materials elicit rapid ingrowth of healthy trabecular tissue while maintaining mechanical strength throughout the bone remodeling process.